We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RACE:NYSEFerrari N.V. Analysis

Data as of 2026-09-06 - not real-time

$409.95

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ferrari N.V. trades at $409.95, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 13.8%. Relative strength is 50.2 — neutral — and the MACD signal is bearish. The recent range runs from support at $404.51 up to resistance at $437.15.
Multiples put this in overvalued territory at a P/E of 38.2. Analyst price targets sit 12.8% above the current price. Revenue is growing at 8.4% on a 22.2% profit margin. The 1.03% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 29.2%, a beta of 0.94 and a maximum drawdown of 37.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Ferrari N.V. NYSE:RACE reported second-quarter results that came in below Wall Street expectations, but investors...Maranello Italy , September 1 2026 – Ferrari N.Ferrari stock remains supported by high profitability and pricing power, with the Maranello-based sp

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 364.95
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 364.95
  • Analyst targets imply +12.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +12.8% versus the current price
  • Profit margin of 22.2% is healthy
  • P/E ratio of 38.2

Key Metrics & Analysis

Financial Health

Revenue Growth8.40%
Profit Margin22.25%
P/E Ratio38.2
ROE45.44%
ROA13.61%
Debt/Equity86.39
P/B Ratio17.0
Op. Cash Flow$2.4B
Free Cash Flow$1.0B

Technical Analysis

TrendBullish
RSI50.2
Support$404.51
Resistance$437.15
MA 20$416.93
MA 50$396.00
MA 200$364.95
MACDBearish
VolumeStable
Fear & Greed Index95.48

Valuation

Fair Value$93.07
Target Price$462.56
Upside/Downside12.83%
GradeOvervalued
TypeGrowth
Dividend Yield1.03%

Risk Assessment

Beta0.94
Volatility29.18%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.